OTC Industry Growth Prospects Lie In Partnerships, Divestments
This article was originally published in The Tan Sheet
Executive Summary
The dynamic of large Rx pharma companies housing older OTC brands may be a significant limiting factor for future growth in the nonprescription drug market
You may also be interested in...
Consumer Shakeup: Procter & Gamble Swallows Gillette
Procter & Gamble's acquisition of Gillette extends the consumer product firm's dominance in the tooth-whitening category
Bristol Consumer Unit Suitors Tasked With Determining Value Of Excedrin
Bristol-Myers Squibb says it will contact potential buyers for its North American Consumer Medicines division "over the coming weeks.
Pfizer’s Listerine Comparisons To Floss Struck Down In NY Court
Listerine is not clinically proven to be as effective in fighting tooth and gum decay as flossing, a New York district judge ruled Jan. 6